Cite
HARVARD Citation
Gardner, L. et al. (n.d.). Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia. American journal of hematology. 89 (9), pp. 896-903. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gardner, L. et al. (n.d.). Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia. American journal of hematology. 89 (9), pp. 896-903. [Online].